Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2269968/aclaris-therapeutics-acrs-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2269968
May 07, 2024 - Aclaris (ACRS) delivered earnings and revenue surprises of 14.29% and 20.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
0
Pages: 1
Page 1